Let’s face it: Most stocks aren’t going to make you a millionaire. Even a stock that delivered 15% annual growth over 30 years wouldn’t turn a $10,000 investment into $1 million. 

To make you a millionaire, a stock has to be in a field with phenomenal growth potential. Ideally, the company should be in its early stages to capitalize on a large portion of that growth. CRISPR Therapeutics (NASDAQ: CRSP) meets these criteria. But could the gene-editing

Read More At Article Source | Article Attribution